InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
14.31
0.00 (0.03%)
Oct 13, 2026, 4:00 PM EDT - Market closed
InMode Revenue
InMode had revenue of $95.59M in the quarter ending June 30, 2026, a decrease of -0.01%. This brings the company's revenue in the last twelve months to $374.63M, down -6.71% year-over-year. In the year 2025, InMode had annual revenue of $370.50M, down -6.16%. That makes InMode the 12,962nd largest company in the world by revenue and 2,477th in the United States.
Revenue (ttm)
$374.63M
Revenue Growth
-6.71%
P/S Ratio
2.19
Revenue / Employee
$567,614
Employees
660
Market Cap
822.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 370.50M | -24.32M | -6.16% |
| Dec 31, 2024 | 394.82M | -97.23M | -19.76% |
| Dec 31, 2023 | 492.05M | 37.78M | 8.32% |
| Dec 31, 2022 | 454.27M | 96.71M | 27.05% |
| Dec 31, 2021 | 357.57M | 151.46M | 73.49% |
| Dec 31, 2020 | 206.11M | 49.75M | 31.81% |
| Dec 31, 2019 | 156.36M | 56.20M | 56.11% |
| Dec 31, 2018 | 100.16M | 46.71M | 87.37% |
| Dec 31, 2017 | 53.46M | 30.37M | 131.59% |
| Dec 31, 2016 | 23.08M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.36B |
| QuidelOrtho | 2.67B |
| Enovis | 2.30B |
| Lumexa Imaging Holdings | 1.04B |
| Varex Imaging | 865.00M |
| SI-BONE | 213.60M |
| Cytek Biosciences | 206.71M |
| Pacific Biosciences of California | 159.27M |
INMD News
- 11 hours ago - InMode sees Q3 revenue $91.8M-$92M, consensus $91.59M - TheFly
- 11 hours ago - InMode sees FY26 revenue $365M-$375M, consensus $370.27M - TheFly
- 11 hours ago - InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - PRNewsWire
- 4 weeks ago - InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool - PRNewsWire
- 2 months ago - InMode Earnings release: Q2 2026 - Filings
- 2 months ago - InMode reports Q2 non-GAAP EPS 35c, consensus 33c - TheFly
- 2 months ago - InMode sees FY26 non-GAAP EPS $1.29-$1.34, consensus $1.32 - TheFly
- 2 months ago - InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 - PRNewsWire